|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: The reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial 显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，20： | 1 |
| 2 | Low- density lipoprotein cholesterol- lowering effects of AMG 145, a monoclonal antibody to proprotein eonvertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the reduction of LDL-C with PCSK9 inhi - bition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R | 2012 | Circulation2012，126，20： | 1 |
| 3 | Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1显示文摘 | Panz V R Bonegio R Raal F J | 2002 | Transplantation2002，73，4： | 1 |
| 4 | Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisinlkexin type 9 serine protease in patients witb heterozygous familial hypercbolesterolernia , the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R et at | 2012 | Circulation2012，126，20： | 1 |
| 5 | Diabetogenic efect of tacrolimus in South African patients undergoing kidney transplantation 显示文摘 | Panz VR Bonegio R Raal F J | 2002 | Transplantation2002，73，4： | 1 |
| 6 | Low-density lipoprotein cholesterol-lower- ing effects of AMG 145, a monoclonal antibody to proprotein convertase subtili- sin/kexin type 9 sefine protease in patients with heterozygous familial hyperchol- esterolemia: the reduction of LDL-C with PCSK9 inhibition in hetemzygous fa- milial hypercholesterolemia disorder ( RUTHERFORD ) randomized trial 显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，： | 1 |
| 7 | Circulating endothelium-related adhesion molecules in black South African patients with Graves' disease显示文摘 | Panz V R Raal F J Wall J R | 2000 | Endocrine(Abstract)2000，12，1： | 1 |
| 8 | Lowdensity lipoprotein cholesterol-lowering effects of AMG 145,a monoclonal antibody to proprotein convertase subtilisin/kexin type 9serine protease in patients with heterozygous familial hypercholesterolemia:the Reduction of LDL-C with PCSK9Inhibition in Heterozygous Familial Hypercholesterolemia Disorder(RUTHERFORD)randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R | 2012 | Circulation2012，126，： | 1 |
| 9 | PCSK9inhibition with evolocumab(AMG 145)in heterozygous familial hypercholesterolaemia(RUTHERFORD-2):a randomised,double-blind,placebo-controlled trial显示文摘 | RAAL F J STEIN E A DUFOUR R | 2015 | Lancet2015，385，： | 1 |
| 10 | ODYSSEY HIGH FH:Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia显示文摘 | GINSBERG H N RADER D RAAL F J | 2014 | Circulation2014，130，： | 1 |
| 11 | Lowdensity lipoprotein cholesterol-lowering effects of AMG 145,a monoclonal antibody to proprotein convertase subtilisin/kexin type 9serine protease in patients with heterozygous familial hypercholesterolemia the reduction of LDL-C with PCSK9inhibition in Heterozygous Familial Hypercholesterolemia Disorder(RUTHERFORD)randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R | 2012 | Circulation2012，126，： | 1 |
| 12 | PCSK9 inhibition with evolocumab ( AMG 145 ) in hetero- zygous familial hypercholesterolaemia (RUTHER- FORD-2 ) : a randomised, double-blind, placebo-con-trolled trial 显示文摘 | RAAL F J STEIN E A DUFOUR R | 2015 | The Lancet2015，385，9965： | 1 |
| 13 | Inhi- bition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia ( TESLA Part B ) : a randomised, double-blind, placebo-controlled trial 显示文摘 | RAAL F J HONARPOUR N BLOM D J | 2015 | The Lancet2015，385，9965： | 1 |
| 14 | Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9显示文摘 | Stein EA Raal F | 2014 | Annu Rev Med2014，65，： | 1 |
| 15 | Homozygous familial hypercholest- erolemia: current perspectives on diagnosis and treatment 显示文摘 | RAAL F J SANTOS RD | 2012 | Atherosclerosis2012，223，2： | 1 |
| 16 | Efficacy and safety of longer-term administration of evolocumab(AMG 145)in patients with hypercholesterolemia:52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C(OSLER)randomized trial显示文摘 | KOREN M J GIUGLIANO R P RAAL F J | 2014 | Circulation2014，129，： | 1 |
| 17 | On the Photophysical Properties of New Luminol Derivatives and their Synthetic Phthal- imide Precursors显示文摘 | Raal P R Robert F Yrene D M | 2010 | Journal of?Fluorescence2010，20，： | 1 |
| 18 | Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonalantibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，20： | 1 |
| 19 | Elevated PCSK9 levels in untreated patients with heterozygous or homozy- gous familial hypercholesterolemia and the response to high-dose statin therapy显示文摘 | Raal F Panz V Immelman A | 2013 | J Am Heart Assoc2013，2，2： | 1 |
| 20 | Low-Density Lipoprotein Cholesterol-Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia: TheReduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Rando- mized Trial显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员